| Model Number |
INT25026UX |
| Medical Device Problem Code |
Component Missing (2306)
|
| Health Effect - Clinical Code |
No Consequences Or Impact To Patient (2199)
|
| Date of Event |
03/31/2020
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
If information is provided in the future, a supplemental report will be issued.
|
| |
|
Event or Problem Description
|
|
During a procedure, an attempt was made to use two integrity rx coronary stent systems to treat a non-tortuous, non-calcified lesion exhibiting 95% stenosis in the mid left anterior descending (lad) artery.There was no damage noted to the devices packaging.There was no issues noted when removing the devices from the hoop.The devices were not inspected before use.Negative prep was performed with no issues noted.The lesion was pre-dilated prior to using the stent with lot number 0009829389.The lesion was not pre-dilated prior to using the stent with lot number 0009900545.The devices did not pass through a previously deployed stent.Resistance was not encountered when advancing the devices.Excessive force was not used during delivery.It was reported that the stents may not have been on the catheter prior to use.It was stated that there is no evidence of the stents in the vessel post balloon inflation.It was noted that several other integrity stents were placed after the first two stents were allegedly deployed and these stents are visible in the vessel.The patient was reported to be alive with no injury.
|
| |
|
Additional Manufacturer Narrative
|
|
Additional information: there were no difficulties noted when removing the protective sheath for both devices.It was later reported that the sheaths of both devices were not inspected to determine whether the stents were removed upon removal of the sheaths and stylettes.The devices were prepared and sheaths were removed by a new member of staff.If information is provided in the future, a supplemental report will be issued.
|
| |
|
Additional Manufacturer Narrative
|
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
| |
|
Search Alerts/Recalls
|